Advances in pathogenesis and treatment of pruritus.

[1]  J. Szepietowski,et al.  Non-analgesic effects of opioids: peripheral opioid receptors as promising targets for future anti-pruritic therapies. , 2012, Current pharmaceutical design.

[2]  David C. Jones.  Pathogenesis of cholestatic itch: Old questions, new answers, and future opportunities , 2012, Hepatology.

[3]  R. Jalan,et al.  Serum autotaxin is increased in pruritus of cholestasis, but not of other origin and responds to therapeutic interventions , 2015 .

[4]  F. Nevens,et al.  Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study. , 2012, Journal of hepatology.

[5]  L. Lazzeroni,et al.  Aversive and Reinforcing Opioid Effects: A Pharmacogenomic Twin Study , 2012, Anesthesiology.

[6]  J. Thornton,et al.  Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial , 2012, BMJ : British Medical Journal.

[7]  Q. H. Tran,et al.  Intravenous butorphanol administration reduces intrathecal morphine-induced pruritus after cesarean delivery: a randomized, double-blind, placebo-controlled study , 2012, Journal of Anesthesia.

[8]  J. Chun,et al.  Targeted Deletion of LPA5 Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of Neuropathic Pain* , 2012, The Journal of Biological Chemistry.

[9]  R. Jalan,et al.  ‘Out‐patient’ albumin dialysis for cholestatic patients with intractable pruritus , 2012, Alimentary pharmacology & therapeutics.

[10]  Nagehan Didem Sarı,et al.  A case report: nasobiliary drainage inducing remission in benign recurrent intrahepatic cholestasis. , 2012, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[11]  T. Pusl,et al.  Pathogenesis and Treatment of Pruritus in Cholestasis , 2012, Drugs.

[12]  D. Escalante-Alcalde,et al.  Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site. , 2013, Nature chemical biology.

[13]  G. Engelmann,et al.  Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus , 2012, Pediatric Nephrology.

[14]  K. Bhakoo,et al.  A placental phenotype for intrahepatic cholestasis of pregnancy. , 2011, Placenta.

[15]  S. Jee,et al.  Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial , 2011, The British journal of dermatology.

[16]  M. Gay,et al.  Proteomic Analysis of Polypeptides Captured from Blood during Extracorporeal Albumin Dialysis in Patients with Cholestasis and Resistant Pruritus , 2011, PloS one.

[17]  J. Muntané,et al.  Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids , 2011, Journal of hepato-biliary-pancreatic sciences.

[18]  W. Vogel,et al.  Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease , 2011, Journal of gastroenterology and hepatology.

[19]  U. Beuers,et al.  [Pruritus in liver disease. Pathogenesis and treatment]. , 2011, Nederlands tijdschrift voor geneeskunde.

[20]  A. Thompson,et al.  Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia , 2010, PAIN®.

[21]  R. D. de Man,et al.  The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: Results of a double‐blind, randomized, placebo‐controlled trial , 2010, Hepatology.

[22]  J. Prieto,et al.  Lysophosphatidic acid is a potential mediator of cholestatic pruritus. , 2010, Gastroenterology.

[23]  U. Beuers,et al.  Bile salts and cholestasis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[24]  Román A. Corfas,et al.  Loss of Inhibitory Interneurons in the Dorsal Spinal Cord and Elevated Itch in Bhlhb5 Mutant Mice , 2010, Neuron.

[25]  G. Gores,et al.  Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.

[26]  A. Parés,et al.  Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. , 2010, Journal of hepatology.

[27]  Román A. Corfas,et al.  Supplemental Information Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb 5 mutant mice , 2010 .

[28]  P. Hasanein.  The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis , 2009, Neuroscience Letters.

[29]  A. Bhalla,et al.  Nasobiliary drainage in acute cholestatic hepatitis with pruritus. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[30]  K. Horie-Inoue,et al.  Identification of Igf2, Igfbp2 and Enpp2 as estrogen-responsive genes in rat hippocampus. , 2009, Endocrine journal.

[31]  F. Lammert,et al.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.

[32]  F. Lammert,et al.  Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine , 2007, Hepatology.

[33]  F. Lammert,et al.  Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. , 2007, Gastroenterology.

[34]  B. Vandermeer,et al.  The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated Pruritus , 2007, The American Journal of Gastroenterology.

[35]  T. Pusl,et al.  Intrahepatic cholestasis of pregnancy , 2007, Orphanet journal of rare diseases.

[36]  A. Rush,et al.  Sertraline as a first‐line treatment for cholestatic pruritus , 2007, Hepatology.

[37]  K. Javanmardi,et al.  Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate. , 2007, European journal of pharmacology.

[38]  A. Leung,et al.  Primary Biliary Cirrhosis , 2007 .

[39]  A. Krasinskas,et al.  Liver Transplantation in Precirrhotic Biliary Tract Disease: Portal Hypertension is Frequently Associated With Nodular Regenerative Hyperplasia and Obliterative Portal Venopathy , 2006, The American journal of surgical pathology.

[40]  Shu-Cheng Chen,et al.  Intradermal pregnenolone sulfate attenuates capsaicin-induced nociception in rats. , 2006, Biochemical and biophysical research communications.

[41]  A. Cowan,et al.  Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats , 2006, Pharmacology Biochemistry and Behavior.

[42]  J. Mogil,et al.  Influence of genotype, dose and sex on pruritogen-induced scratching behavior in the mouse , 2006, Pain.

[43]  M. Swain,et al.  Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated. , 2006, Journal of hepatology.

[44]  J. Devlin,et al.  Nasobiliary drainage induces long‐lasting remission in benign recurrent intrahepatic cholestasis , 2006, Hepatology.

[45]  J. Oosting,et al.  Improved device for measuring scratching activity in patients with pruritus , 1998, Medical and Biological Engineering and Computing.

[46]  S. Taylor-Robinson,et al.  ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy , 2005, Gut.

[47]  A. Greiner,et al.  Effective Opiate-Receptor Antagonist Therapy of Cholestatic Pruritus Induced by an Oral Contraceptive , 2005, Journal of pediatric gastroenterology and nutrition.

[48]  T. Hashimoto,et al.  Itch-Scratch Responses Induced by Lysophosphatidic Acid in Mice , 2004, Pharmacology.

[49]  H. Ueda,et al.  Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling , 2004, Nature Medicine.

[50]  J. Rodés,et al.  Extracorporeal Albumin Dialysis: A Procedure for Prolonged Relief of Intractable Pruritus in Patients with Primary Biliary Cirrhosis , 2004, American Journal of Gastroenterology.

[51]  N. Bergasa.  An approach to the management of the pruritus of cholestasis. , 2004, Clinics in liver disease.

[52]  P. Meier,et al.  Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. , 2004, Pharmacogenetics.

[53]  H. Schwaighofer,et al.  Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[54]  J. Hoofnagle,et al.  Pruritus as a Presenting Symptom of Chronic Hepatitis C , 1998, Digestive Diseases and Sciences.

[55]  E. Lebovics,et al.  Pruritus in Chronic Hepatitis C (Association with High Serum Bile Acids, Advanced Pathology, and Bile Duct Abnormalities) , 1997, Digestive Diseases and Sciences.

[56]  N. Bergasa,et al.  The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis. , 2003, Life sciences.

[57]  H. Nagai,et al.  Evaluation and Characterization of Mouse Scratching Behavior by a New Apparatus, MicroAct , 2003, Skin Pharmacology and Physiology.

[58]  E. Coronel,et al.  Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. , 2002, Journal of hepatology.

[59]  J. Neuberger,et al.  Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. , 2002, QJM : monthly journal of the Association of Physicians.

[60]  E. Schiff,et al.  Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease , 2002, American Journal of Gastroenterology.

[61]  J. Marin,et al.  Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism. , 2002, Clinical science.

[62]  S. Saarikoski,et al.  Risk of obstetric cholestasis in sisters of index patients , 2001, Clinical genetics.

[63]  F. Berr,et al.  Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC). , 2001, Zeitschrift fur Gastroenterologie.

[64]  M. J. Link,et al.  Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease , 2001, American Journal of Gastroenterology.

[65]  N. Bergasa,et al.  Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[66]  S. Welch,et al.  Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification. , 1999, The Journal of pharmacology and experimental therapeutics.

[67]  M. Schemper,et al.  Treatment of pruritus in chronic liver disease with the 5‐hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo‐controlled, double‐blind cross‐over trial , 1998, European journal of gastroenterology & hepatology.

[68]  L. Sun,et al.  Gender differences in pain sensitivity and responses to analgesia. , 1998, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.

[69]  Hermann O. Handwerker,et al.  Specific C-Receptors for Itch in Human Skin , 1997, The Journal of Neuroscience.

[70]  W. Hop,et al.  Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. , 1997, Gastroenterology.

[71]  D. Alling,et al.  Cholestasis in the male rat is associated with naloxone-reversible antinociception. , 1994, Journal of hepatology.

[72]  G. Gores,et al.  Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis. , 1994, The American journal of gastroenterology.

[73]  S. Kivinen,et al.  Inheritance of intrahepatic cholestasis of pregnancy in one kindred , 1993, Clinical genetics.

[74]  E. Schulman,et al.  Raised histamine concentrations in chronic cholestatic liver disease. , 1990, Gut.

[75]  M. Losowsky,et al.  Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine. , 1989, Journal of hepatology.

[76]  S. Carruthers,et al.  Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. , 1988, Gastroenterology.

[77]  J. Neuberger,et al.  Primary biliary cirrhosis in men. , 1986, Gut.

[78]  S. Rossetti,et al.  Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids. , 1984, Methods and findings in experimental and clinical pharmacology.

[79]  W. Braun,et al.  Familial recurrent intrahepatic cholestasis of pregnancy: a genetic study providing evidence for transmission of a sex-limited, dominant trait. , 1983, Gastroenterology.

[80]  B. Gilchrest,et al.  ULTRAVIOLET PHOTOTHERAPY OF UREMIC PRURITUS , 1979, International journal of dermatology.

[81]  K. Arndt,et al.  Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. , 1979, Annals of internal medicine.

[82]  J. Bloomer,et al.  THE YALE JOURNAL OF BIOLOGY AND MEDICINE 52 (1979), 77-82 Itch in Liver Disease: Facts and Speculations , 1978 .

[83]  J. Ribalta,et al.  Idiopathic cholestasis of pregnancy in a large kindred. , 1976, Gut.

[84]  J. Burton,et al.  Pruritic Effect of Bile Salts , 1974, British medical journal.